221 related articles for article (PubMed ID: 34694223)
1. Single-dose intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of post-operative anaemia in colorectal cancer patients: a randomised controlled trial.
Laso-Morales MJ; Vives R; Bisbe E; García-Erce JA; Muñoz M; Martínez-López F; Carol-Boeris F; Pontes-García C
Blood Transfus; 2022 Jul; 20(4):310-318. PubMed ID: 34694223
[TBL] [Abstract][Full Text] [Related]
2. Single dose of intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of postoperative anaemia in colorectal cancer patients: study protocol for a randomised controlled trial.
Laso-Morales MJ; Vives R; Vallejo-Tarrat A; Caló N; Valle-Beltran A; Pontes C
Trials; 2019 Jan; 20(1):23. PubMed ID: 30616657
[TBL] [Abstract][Full Text] [Related]
3. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial.
Khalafallah AA; Yan C; Al-Badri R; Robinson E; Kirkby BE; Ingram E; Gray Z; Khelgi V; Robertson IK; Kirkby BP
Lancet Haematol; 2016 Sep; 3(9):e415-25. PubMed ID: 27570088
[TBL] [Abstract][Full Text] [Related]
4. Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial.
Talboom K; Borstlap WAA; Roodbeen SX; Bruns ERJ; Buskens CJ; Hompes R; Tytgat KMAJ; Tuynman JB; Consten ECJ; Heuff G; Kuiper T; van Geloven AAW; Veldhuis GJ; van der Hoeven JAB; Gerhards MF; Sietses C; Spinelli A; van de Ven AWH; van der Zaag ES; Westerterp M; van Westreenen HL; Dijkgraaf ML; Juffermans NP; Bemelman WA;
Lancet Haematol; 2023 Apr; 10(4):e250-e260. PubMed ID: 36863386
[TBL] [Abstract][Full Text] [Related]
5. Preoperative intravenous iron for anaemia in elective major open abdominal surgery: the PREVENTT RCT.
Richards T; Baikady RR; Clevenger B; Butcher A; Abeysiri S; Chau M; Swinson R; Collier T; Dodd M; Dyck LV; Macdougall I; Murphy G; Browne J; Bradbury A; Klein A
Health Technol Assess; 2021 Feb; 25(11):1-58. PubMed ID: 33632377
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.
Vanobberghen F; Lweno O; Kuemmerle A; Mwebi KD; Asilia P; Issa A; Simon B; Mswata S; Schmidlin S; Glass TR; Abdulla S; Daubenberger C; Tanner M; Meyer-Monard S
Lancet Glob Health; 2021 Feb; 9(2):e189-e198. PubMed ID: 33245866
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer.
Keeler BD; Simpson JA; Ng O; Padmanabhan H; Brookes MJ; Acheson AG;
Br J Surg; 2017 Feb; 104(3):214-221. PubMed ID: 28092401
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty.
Bisbe E; Moltó L; Arroyo R; Muniesa JM; Tejero M
Br J Anaesth; 2014 Sep; 113(3):402-9. PubMed ID: 24780615
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC
Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
[TBL] [Abstract][Full Text] [Related]
10. Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients.
Borstlap WAA; Buskens CJ; Tytgat KMAJ; Tuynman JB; Consten ECJ; Tolboom RC; Heuff G; van Geloven N; van Wagensveld BA; C A Wientjes CA; Gerhards MF; de Castro SMM; Jansen J; van der Ven AWH; van der Zaag E; Omloo JM; van Westreenen HL; Winter DC; Kennelly RP; Dijkgraaf MGW; Tanis PJ; Bemelman WA
BMC Surg; 2015 Jun; 15():78. PubMed ID: 26123286
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iron administration before cardiac surgery reduces red blood cell transfusion in patients without anaemia.
Friedman T; Dann EJ; Bitton-Worms K; Makhoul M; Glam R; Weis A; Tam DY; Bolotin G
Br J Anaesth; 2023 Dec; 131(6):981-988. PubMed ID: 37838604
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: An open-label, multicenter, randomized study.
Lee S; Ryu KJ; Lee ES; Lee KH; Lee JJ; Kim T
J Obstet Gynaecol Res; 2019 Apr; 45(4):858-864. PubMed ID: 30932300
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial.
Jose A; Mahey R; Sharma JB; Bhatla N; Saxena R; Kalaivani M; Kriplani A
BMC Pregnancy Childbirth; 2019 Feb; 19(1):54. PubMed ID: 30717690
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial.
Neogi SB; Devasenapathy N; Singh R; Bhushan H; Shah D; Divakar H; Zodpey S; Malik S; Nanda S; Mittal P; Batra A; Chauhan MB; Yadav S; Dongre H; Saluja S; Malhotra V; Gupta A; Sangwan R; Radhika AG; Singh A; Bhaskaran S; Kotru M; Sikka M; Agarwal S; Francis P; Mwinga K; Baswal D
Lancet Glob Health; 2019 Dec; 7(12):e1706-e1716. PubMed ID: 31708151
[TBL] [Abstract][Full Text] [Related]
15. The feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancer.
Keeler BD; Simpson JA; Ng S; Tselepis C; Iqbal T; Brookes MJ; Acheson AG
Colorectal Dis; 2014 Oct; 16(10):794-800. PubMed ID: 24916374
[TBL] [Abstract][Full Text] [Related]
16. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.
Spahn DR; Schoenrath F; Spahn GH; Seifert B; Stein P; Theusinger OM; Kaserer A; Hegemann I; Hofmann A; Maisano F; Falk V
Lancet; 2019 Jun; 393(10187):2201-2212. PubMed ID: 31036337
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
Geisser P; Rumyantsev V
Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
[TBL] [Abstract][Full Text] [Related]
18. Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil.
Montano-Pedroso JC; Bueno Garcia E; Alcântara Rodrigues de Moraes M; Francescato Veiga D; Masako Ferreira L
Lancet Haematol; 2018 Jul; 5(7):e310-e320. PubMed ID: 29958570
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled, open label non-inferiority trial of intravenous ferric carboxymaltose versus iron sucrose in patients with iron deficiency anemia in China.
Jin J; Ran Z; Noseda E; Roubert B; Marty M; Mezzacasa A; Göring UM
Front Med; 2024 Feb; 18(1):98-108. PubMed ID: 37897561
[TBL] [Abstract][Full Text] [Related]
20. The impact of pre-operative intravenous iron on quality of life after colorectal cancer surgery: outcomes from the intravenous iron in colorectal cancer-associated anaemia (IVICA) trial.
Keeler BD; Dickson EA; Simpson JA; Ng O; Padmanabhan H; Brookes MJ; Acheson AG;
Anaesthesia; 2019 Jun; 74(6):714-725. PubMed ID: 30963552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
